US Broker Ratings

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing a 40% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) stands at the intersection of innovation and strategic growth within the healthcare sector. With a market capitalization of $2.83 billion, the..

Brookdale Senior Living Inc. (BKD): Investor Outlook and Potential Upside with a 7.24% Target

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling case for investors interested in the healthcare sector, particularly in the medical care facilities industry. Headquartered in..

LivaNova PLC (LIVN) Stock Analysis: Navigating the 11.45% Potential Upside Amidst Strong Buy Ratings

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical devices industry, is capturing investor attention with its 11.45% potential upside and a robust lineup of..

MannKind Corporation (MNKD) Stock Analysis: Exploring a Potential 89.79% Upside in the Biotech Arena

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is attracting keen investor interest with a notable potential upside of 89.79%. With a market..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Play with 169% Potential Upside

PACS Group, Inc. (NASDAQ: PACS) is drawing significant investor attention in the healthcare sector, offering a compelling opportunity with a notable 169% potential upside. As a..

Indivior PLC (INDV) Stock Analysis: Analyst Ratings Reveal a Promising 17.89% Upside Potential

Indivior PLC (NASDAQ: INDV), a prominent player in the healthcare sector, is gaining attention for its innovative solutions in the treatment of opioid dependence and related..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 61% Potential Upside in Innovative Biotech

Disc Medicine, Inc. (NASDAQ: IRON), a prominent player in the biotechnology sector, has captured the attention of investors with its robust growth potential and innovative approach..

Select Medical Holdings Corp (SEM): Investor Outlook Reveals 34.59% Potential Upside Amid Healthcare Growth

Select Medical Holdings Corp (NYSE: SEM) stands as a notable player in the healthcare sector, operating a diverse portfolio of critical illness recovery hospitals, rehabilitation hospitals,..

Astrana Health Inc. (ASTH) Stock Analysis: Strong Buy Ratings and Nearly 49% Potential Upside

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, has caught the attention of investors with a significant potential upside of nearly 49%. This..

GRAIL, Inc. (GRAL) Stock Analysis: Exploring Its 5.94% Potential Upside in the Healthcare Sector

GRAIL, Inc. (NASDAQ: GRAL) is carving out a niche in the competitive healthcare sector with its pioneering approach to multi-cancer detection. Operating within the Diagnostics &..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a 36.30% Revenue Growth Amidst a 11.64% Potential Upside

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a dynamic player in the healthcare sector, stands out for its pioneering work in the biotechnology industry. With a current market..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring the 30% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a biotechnology stalwart in the healthcare sector, is making waves with its promising pipeline and notable analyst ratings. With a market..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Contender with 154% Potential Upside

Apogee Therapeutics, Inc. (APGE) is emerging as a noteworthy player in the biotechnology sector, captivating investor interest with its significant potential upside. With a market capitalization..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A 79.79% Upside Drives Investor Intrigue

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology firm, has captured the attention of investors with its promising pipeline and a substantial potential upside of 79.79%...

Clover Health Investments, Corp (CLOV): Investor Outlook Highlights Potential 33% Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a prominent player in the healthcare plans industry, is catching the attention of investors due to its attractive potential upside..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Unveiling a 99% Potential Upside in Rare Endocrine Therapeutics

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands at the forefront of innovation in biotechnology, with a keen focus on novel therapeutics for rare endocrine diseases and related..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: A 72.57% Potential Upside Worth Watching

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a notable player in the healthcare sector, specifically within the medical devices industry. Based in San Diego, California, Tandem..

Schrödinger, Inc. (SDGR) Stock Analysis: Exploring a Potential 44.6% Upside with Strong Buy Ratings

Schrödinger, Inc. (NASDAQ: SDGR) stands at the intersection of healthcare innovation and computational technology. Specializing in the development of a physics-based computational platform, Schrödinger facilitates the..

Privia Health Group (PRVA) Stock Analysis: A 27.81% Potential Upside Beckons Investors

Investors in search of promising opportunities within the healthcare sector might find Privia Health Group, Inc. (NASDAQ: PRVA) an intriguing prospect. With its current market cap..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking the 45.35% Potential Upside in Medical Devices

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing case for investors seeking growth potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds